BioAge Labs, Inc.
USD16.54
-0.66 (-3.84%)
CEO
Kristen Fortney
IPO Date
2024-09-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.73
Prev. Close
$17.20
Day Low
$15.88
Day High
$16.90
52W Low
$3.93
52W High
$24.00
Market Cap
$0.62B
Volume
0.38M
| 3,542 |
| $4.38 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 5,437 | $4.11 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 3,383 | $6.57 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | S-Sale | Disposed | 8,820 | $17.81 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Disposed | 5,437 | $4.11 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Disposed | 3,383 | $6.57 |
| 3 Mar 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 5,433 | $4.11 |
| 3 Mar 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 2,000 | $6.57 |
| 3 Mar 2026 | RUBIN PAUL D | Chief Medical Officer | S-Sale | Disposed | 7,433 | $20.30 |